Back to Search
CHARLES RITTENBERG, MD.
MD.
Maternal & Fetal Medicine Physician
NPI: 1376658856IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
22689(SC)
Gynecology Physician
Obstetrics & Gynecology — Gynecology
Code: 207VG0400X
22689(SC)
Maternal & Fetal Medicine PhysicianPrimary
Obstetrics & Gynecology — Maternal & Fetal Medicine
Code: 207VM0101X
22689(SC)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 2000
Research & Publications (19)
Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillance.
PMID 19301566·J Reprod Med·2009
4-observational
Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
PMID 18928983·Am J Obstet Gynecol·2008
4-observational
Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting.
PMID 17826412·Am J Obstet Gynecol·2007
8-other
Psychosocial care for patients and their families is integral to supportive care in cancer: MASCC position statement.
PMID 19609571·Support Care Cancer·2010
6-review
Development of the MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer.
PMID 19590904·Support Care Cancer·2010
8-other
South Carolina Partners for Preterm Birth Prevention: a regional perinatal initiative for the reduction of premature birth in a Medicaid population.
PMID 18928985·Am J Obstet Gynecol·2008
8-other
Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an international survey.
PMID 18197437·Support Care Cancer·2008
8-other
A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre.
PMID 17926070·Support Care Cancer·2008
8-other
Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool.
PMID 17509816·J Pain Symptom Manage·2007
8-other
Reader asks Oncology Nursing Forum and Clinical Journal of Oncology Nursing editors about terminology.
PMID 16568586·Oncol Nurs Forum·2006
8-other
Multidisciplinary oncology panel develops international antiemetic consensus guidelines.
PMID 15918646·ONS News·2005
8-other
Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
PMID 15565277·Support Care Cancer·2005
6-review
Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement.
PMID 15480812·Support Care Cancer·2005
6-review
The next generation of chemotherapy-induced nausea and vomiting prevention and control: a new 5-HT3 antagonist arrives.
PMID 15208825·Clin J Oncol Nurs·2004
4-observational
Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer.
PMID 15206013·Support Care Cancer·2004
4-observational
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
PMID 12712486·Cancer·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 171 ASHLEY AVE
CHARLESTON, SC 29425 - Phone
- (843) 792-1414
Quick Facts
- NPI
- 1376658856
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 26
- Publications
- 19
Are you this provider?
Claim Your Profile